Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
Objectives: The biochemical serum markers free β-human chorionic gonadotropin (hCGβ) and pregnancy associated plasma protein A (PAPP-A), used in screening for trisomy 21 (T21), trisomy 18 (T18), and trisomy 13 (T13) during the first trimester, can be measured on different laboratory instruments e.g....
Main Authors: | Anna Elise Engell, Elin Rebecka Carlsson, Finn Stener Jørgensen, Steen Sørensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Practical Laboratory Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551717300070 |
Similar Items
-
First trimester prenatal screening in multiple pregnancies. Part II: serum proteins PAPP-A and β-hCG as markers of adverse pregnancy outcomes
by: V. I. Tsibizova, et al.
Published: (2020-04-01) -
First trimester prenatal screening in multiple pregnancies. Part I: comparative analysis of serum proteins PAPP-A and p-hCG in pregnancies conceived spontaneously or by in vitro fertilization
by: V. I. Tsibizova, et al.
Published: (2020-04-01) -
The impact of temporal variability of biochemical markers PAPP-A and free β-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study
by: Kos Milan, et al.
Published: (2010-07-01) -
Evaluation of Maternal Serum PAPP-A and hCG Levels at 10-14 Weeks of Gestation in Hyperemesis Gravidarum
by: Anıl Turhan Çakır, et al.
Published: (2020-10-01) -
Predictive value of extreme low PAPP-A, free βhCG and extreme high mean uterine artery pulsatility index in the first trimester for fetal growth restriction
by: Lukić Relja, et al.
Published: (2020-01-01)